Segment Transport Versus Acute Shortening In The Treatment of Tibial Pseudarthroses With Bone Loss

TIBIA PSEUDOARTHROSES Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01246934
• Other study ID #: BVUORT001
• Status: Completed
• Phase: N/A
• First received: November 23, 2010
• Last updated: November 23, 2010
• Start date: October 2009
• Est. completion date: February 2010

Study information

• Verified date: November 2010
• Source: Bezmialem Vakif University
• Contact: n/a
• Is FDA regulated: No
• Health authority: (Turkey)Bezmialem Vakif Universitesi:Turkey
• Study type: Interventional

Clinical Trial Summary

In this study the investigators are presenting the advantages as well as the disadvantages of ACUTE SHORTENING AND RELENGTHENINIG VS SEGMENT TRANSPORT methods.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: February 2010
• Est. primary completion date: December 2009
• Gender: Both
• Age group: 13 Years to 50 Years

Eligibility

Inclusion Criteria:TIBIA PSEUDOARTHROSES -

Exclusion Criteria:BONE LOSS GREATER THAN 10 CM

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pseudarthrosis
• TIBIA PSEUDOARTHROSES

Intervention

Other:
• ASR METHOD

Locations

Country	Name	City	State
Turkey	Cengiz Sen	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Paley D, Sen C, Tetsworth K. Acute Shortening With Subsequent Relengthening Versus Bone Transport In The Treatment Of Tibial Bone Defect, 11th Asami North America Annual Scientific Meeting, February 18-25, Berkeley Ca, 2001

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	TREATMENT PERIOD AND COMPLICATION RATE